12:30pm PDT - July 20th, 2023

Arbitration Panel Finds that Syneos Health (NASDAQ: SYNH) Failed to Use Commercially Reasonable Efforts in Conducting its Trial for FSD 201: https://t.co/cCGkPu9Sf7

0 retweets   0 likes  - Psychedelic Invest (@psyinvest)